إعلان
إعلان

SCYX

SCYX logo

SCYNEXIS, Inc.

0.64
USD
برعاية
0.00
-0.06%
٠٧ يناير, ١٥:٤١ UTC -5
مغلق
exchange

بعد الإغلاق

0.66

+0.02
+3.43%

تقارير أرباح SCYX

النسبة الإيجابية المفاجئة

SCYX تفوق 29 من 40 آخر التقديرات.

73%

التقرير التالي

بيانات التقرير القادم
١٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$8.26M
/
$0.12
التغير الضمني من Q3 25 (Revenue/ EPS)
+2373.65%
/
-170.59%
التغير الضمني من Q4 24 (Revenue/ EPS)
+745.65%
/
-233.33%

SCYNEXIS, Inc. earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, SCYX reported earnings of -0.17 USD per share (EPS) for Q3 25, beating the estimate of -0.20 USD, resulting in a 16.67% surprise. Revenue reached 334.00 ألف, compared to an expected 150.62 ألف, with a 121.75% difference. The market reacted with a -5.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of 0.12 USD, with revenue projected to reach 8.26 مليون USD, implying an نقصان of -170.59% EPS, and زيادة of 2373.65% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, SCYNEXIS, Inc. reported EPS of -$0.17, beating estimates by 16.67%, and revenue of $334.00K, 121.75% above expectations.
The stock price moved down -5.48%, changed from $0.63 before the earnings release to $0.60 the day after.
The next earning report is scheduled for ١٠ مارس ٢٠٢٦.
Based on 5 المحللين, SCYNEXIS, Inc. is expected to report EPS of $0.12 and revenue of $8.26M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان